Buglova S E, Sokolakov V I, Pilotovich V S, Gomolko N N, Chizh K A, Vlasik V A, Finin V S
Urol Nefrol (Mosk). 1994 Jul-Aug(4):27-30.
The authors studied therapeutic potential and mechanism of action of low-intensity low-energy laser irradiating the skin at the site of the projection of the transplanted kidney poles through the development of chronic rejection or chronic pyelonephritis. The trial included 7 kidney recipients and 9 controls with primary chronic pyelonephritis. The treatment course implied 10 daily session of 20 minutes duration of He-Ne laser irradiation which was preceded by clinical-laboratory evaluation of the blood and urine, cellular and humoral immunity, hemostasis, central hemodynamics, local and mediator hormones, factors of nonspecific resistance, spin probe characteristics. The effect appeared contradictory. It is thought valid to combine quantum and drug therapy thus achieving optimal therapeutic effects and preventing side effects.
作者通过慢性排斥反应或慢性肾盂肾炎的发展过程，研究了低强度低能量激光照射移植肾极投影部位皮肤的治疗潜力和作用机制。该试验纳入了7名肾移植受者和9名原发性慢性肾盂肾炎患者作为对照。治疗过程为每天进行10次，每次20分钟的氦氖激光照射，照射前对血液和尿液、细胞和体液免疫、止血、中心血流动力学、局部和介质激素、非特异性抵抗因子、自旋探针特性进行临床实验室评估。结果呈现出矛盾性。认为将量子疗法和药物疗法相结合是有效的，从而实现最佳治疗效果并预防副作用。
